SCHEMBL13330592

SCHEMBL13330592

Cc1cc(C2CC2C(=O)O)c(F)cc1-c1nc(-c2cn3cc(C(C)(F)F)cc(Cl)c3n2)no1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 3/20 0.36
S1PR5 Q9H228 3/20 0.36
S1PR3 Q99500 2/20 0.36
NPC1 O15118 4/20 0.34
NFKB1 P19838 4/20 0.34
RAB9A P51151 4/20 0.34
NFKB2 Q00653 4/20 0.34
RELA Q04206 4/20 0.34
SMN1; SMN2 Q16637 4/20 0.34
MAPT P10636 2/20 0.34
LMNA P02545 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
RECQL P46063 1/20 0.34
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
PKM P14618 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3340521 0.94 NPC1 (0.41) S1PR1S1PR5S1PR3NPC1NFKB1
SCHEMBL3341573 0.88 NPC1 (0.41) S1PR1S1PR5S1PR3NPC1NFKB1
SCHEMBL3342516 0.82 NPC1 (0.42) S1PR1S1PR5S1PR3NPC1NFKB1
SCHEMBL3338529 0.82 NPC1 (0.42) S1PR1S1PR5S1PR3NPC1NFKB1
SCHEMBL13326585 0.80 NPC1 (0.44) S1PR1S1PR5S1PR3NPC1NFKB1
SCHEMBL3340743 0.80 NPC1 (0.44) S1PR1S1PR5S1PR3NPC1NFKB1
SCHEMBL3342134 0.78 NPC1 (0.36) S1PR1S1PR5S1PR3NPC1NFKB1
SCHEMBL3340560 0.76 SMN1; SMN2 (0.48) S1PR1S1PR5S1PR3NPC1NFKB1
SCHEMBL3339900 0.76 NPC1 (0.46) S1PR1S1PR5S1PR3NPC1NFKB1
SCHEMBL2498884 0.76 S1PR1 (0.54) S1PR1S1PR5S1PR3NPC1NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010065760-A1 IMIDAZO [1,2A] PYRIDINE DERIVATIVES, THEIR USE AS S1P1 AGONISTS AND METHODS FOR THEIR PRODUCTION EXELIXIS, INC. (US) 2010-06-10 WO disclosed